Cadus Valuation

Cadus Corporation -- USA Stock  

USD 1.46  0.01  0.69%

Cadus shows prevailing Real Value of $1.1906999999999999 per share. The current price of the firm is $1.46. Based on Macroaxis valuation methodology, the firm appears to be over valued. Macroaxis approximates value of Cadus from analyzing the firm fundamentals such as Current Valuation of 34.55M and Return On Equity of (3.64)% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.
Investment Horizon     30 Days    Login   to change
Cadus Corporation is rated below average in price to earning category among related companies. It is rated below average in price to book category among related companies .
Over Valued
December 16, 2017
1.46
Market Value
Downside upside
1.19
Real Value
Target Price Odds
 Above  Below  
11.54
Upside
Upside upside
Cadus is exceptionally risky asset. Calculation of real value of Cadus is based on 1 month time horizon. Increasing Cadus time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Market Capitalization

Cadus Market Capitalization Analysis
Cadus Corporation is rated below average in market capitalization category among related companies. Market capitalization of Biotechnology industry is now estimated at about 89.81 Billion. Cadus adds roughly 38.43 Million in market capitalization claiming only tiny portion of stocks in Biotechnology industry.
Capitalization  Total debt  Workforce  Valuation  Revenue